Therapeutic Areas
Synexus SA staff of Synexus SA has conducted almost 80 studies since inception. The majority of studies were Phase 2-3 studies in a variety of different patient populations in the therapeutic areas below. Synexus SA sites are regularly amongst the top-enrolling research sites world-wide.
- Feasibility, data collection and proposal
- Vaccines
- Infectious diseases
- HIV and related infections
- Diabetes & Endocrinology
- Respiratory
- Rheumatology
- Cardiovascular
- Women’s Health
- Musculo-skeletal
- Other
THERAPY AREA EXPERTISE (October 2012)
| THERAPEUTIC AREA | ONGOING | COMPLETED | TO START | BE/BA | Ph1 | Ph2 a&b | Ph3 | Ph4 |
| Cardiovascular | 1 | 12 | 1 | 4 | 1 | 8 | 1 | |
| Diabetes and Endocrinology | 2 | 13 | 2 | 2 | 4 | 11 | ||
| Gastroenterology | 4 | 2 | 2 | |||||
| HIV | 1 | 6 | 3 | 2 | 2 | |||
| Infectious Diseases / Anti-infectives | 2 | 23 | 1 | 7 | 1 | 1 | 16 | 1 |
| Musculo-Skeletal / Rheumatology | 3 | 10 | 1 | 1 | 13 | |||
| Nephrology | 1 | 1 | 2 | |||||
| Neurology | 1 | 2 | 2 | 1 | ||||
| Other/Devices | 1 | 6 | 1 | 1 | 5 | |||
| Respiratory / Allergies | 1 | 9 | 2 | 10 | 2 | |||
| Surgical / Post-operative | 11 | 5 | 6 | |||||
| Vaccines | 1 | 11 | 12 | |||||
| 14 | 108 | 7 |
STUDIES DONE PER THERAPY AREA
EXAMPLES OF HIGH VOLUME STUDIES AT SYNEXUS SA SITES
| YEAR | STUDY / INDICATION | NUMBER OF PATIENTS | |||
| PLANNED | ACTUAL | TIME | SITES | ||
| 2011 | Type 2 Diabetes | 18 | 31 | 8 Weeks | 1 DRC* |
| 2010 | Gout | 9 | 27 | 6 Months | 1 DRC |
| 2009 | Osteoporosis | 400 | 457 | 7 Months | 3* |
| 2009 | Osteoporosis | 210 | 214 | 7 Months | 1 DRC* |
| 2006 | Rotavirus Vaccine | 1000 | 1194 | 3 Months | 6* |
| 2006 | Rotavirus Vaccine | 900 | 986 | 3 Months | 4 |
| 2005 | Pentavalent Paediatric Vaccine | 360 | 360 | 2 Months | 4 |
| 2003 / 2004 | Oral Candidiasis in HIV | 220 | 248 | 9 Months | 7* |
| 2002 | Adult Flu Vaccine (>60yrs) | 160 | 288 | 10 Days | 4 |
| * Top enrolling sites worldwide | |||||